Newer Disease-Modifying Therapies Show Promise in Pediatric-Onset Multiple Sclerosis
In a single-center, retrospective study, researchers evaluated the effects of treatment with nDMTs compared with iDMTs in a cohort of patients with POMS.
In a single-center, retrospective study, researchers evaluated the effects of treatment with nDMTs compared with iDMTs in a cohort of patients with POMS.
A virus dangerous to infants is spreading across the United States, and parents and pediatricians should be on the lookout for symptoms.
Children aged 9 to 13 years in the United States sleep an average of 7.45 hours/day.
Researchers sought to assess OSA symptoms and age of OSA diagnosis in children with and without ASD.
Guidance is presented for the management of visual disorders following a concussion among children.
Researchers sought to determine whether in-utero exposure to COVID-19 is associated with a greater risk for neurodevelopmental disorder at year 1.
Researchers sought to investigate the factors that may modify the association between neurodevelopmental disorders and the risk for being bullied.
Researchers sought to evaluate whether children born to women who use SSRIs or SNRIs during pregnancy have a higher risk for neonatal seizures and epilepsy.
Among adolescents, new-onset and worsened headaches during the COVID-19 pandemic were associated with significantly higher depression and general anxiety scores.
Researchers sought to evaluate the efficacy and tolerability of clobazam in pediatric patients in regards to seizure semiology, epileptic syndromes, and etiology-specific epileptic seizures.